How much did Cryosite achieve in EBIT for the current year?
In the current year, Cryosite has achieved an EBIT of 2.05 M AUD.
Cryosite EBIT 2024
Cryosite EBIT
2.05 M AUD
Ticker
CTE.AX
ISIN
AU000000CTE1
WKN
621943
In 2024, Cryosite's EBIT was 2.05 M AUD, a 34.78% increase from the 1.52 M AUD EBIT recorded in the previous year.
The Cryosite EBIT history
| YEAR | EBIT (undefined AUD) |
|---|---|
| 2024 | 2.05 |
| 2023 | 1.52 |
| 2022 | 1.88 |
| 2021 | 1.21 |
| 2020 | 0.81 |
| 2019 | 0.04 |
| 2018 | 0.32 |
| 2017 | -0.02 |
| 2016 | 0.44 |
| 2015 | 0.61 |
| 2014 | 0.68 |
| 2013 | 1.19 |
| 2012 | 1.03 |
| 2011 | 0.32 |
| 2010 | 0.03 |
| 2009 | -0.2 |
| 2008 | 0.46 |
| 2007 | 0.38 |
| 2006 | 0.11 |
| 2005 | -0.61 |
Cryosite Revenue, EBIT, Net Income AU000000CTE1 · 621943
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Cryosite, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cryosite from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cryosite’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Cryosite. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Cryosite’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Cryosite’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cryosite’s growth potential.
Cryosite Revenue, EBIT and net profit per share
| Date | Cryosite Revenue | Cryosite EBIT | Cryosite Net Income |
|---|---|---|---|
| 2024 | 12.61 M undefined | 2.05 M undefined | 1.84 M undefined |
| 2023 | 11.94 M undefined | 1.52 M undefined | 1.41 M undefined |
| 2022 | 11.76 M undefined | 1.88 M undefined | 1.36 M undefined |
| 2021 | 10.02 M undefined | 1.21 M undefined | 652,570 undefined |
| 2020 | 9.01 M undefined | 806,520 undefined | 1.48 M undefined |
| 2019 | 7.97 M undefined | 42,590 undefined | -1.72 M undefined |
| 2018 | 5.92 M undefined | 318,370 undefined | -1.24 M undefined |
| 2017 | 5.88 M undefined | -20,760 undefined | 225,100 undefined |
| 2016 | 10.14 M undefined | 439,260 undefined | 302,470 undefined |
| 2015 | 9.84 M undefined | 608,990 undefined | 455,170 undefined |
| 2014 | 9.42 M undefined | 680,000 undefined | 510,000 undefined |
| 2013 | 8.76 M undefined | 1.19 M undefined | 1.25 M undefined |
| 2012 | 8.02 M undefined | 1.03 M undefined | 1.02 M undefined |
| 2011 | 6.66 M undefined | 320,000 undefined | 330,000 undefined |
| 2010 | 6.14 M undefined | 30,000 undefined | 0 undefined |
| 2009 | 6.32 M undefined | -200,000 undefined | 10,000 undefined |
| 2008 | 6.69 M undefined | 460,000 undefined | 450,000 undefined |
| 2007 | 4.9 M undefined | 380,000 undefined | 920,000 undefined |
| 2006 | 4.25 M undefined | 110,000 undefined | 100,000 undefined |
| 2005 | 3.06 M undefined | -610,000 undefined | -620,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 3.06 M AUD | -610,000 AUD | -620,000 AUD |
| 2006 | 4.25 M AUD | 110,000 AUD | 100,000 AUD |
| 2007 | 4.9 M AUD | 380,000 AUD | 920,000 AUD |
| 2008 | 6.69 M AUD | 460,000 AUD | 450,000 AUD |
| 2009 | 6.32 M AUD | -200,000 AUD | 10,000 AUD |
| 2010 | 6.14 M AUD | 30,000 AUD | 0 AUD |
| 2011 | 6.66 M AUD | 320,000 AUD | 330,000 AUD |
| 2012 | 8.02 M AUD | 1.03 M AUD | 1.02 M AUD |
| 2013 | 8.76 M AUD | 1.19 M AUD | 1.25 M AUD |
| 2014 | 9.42 M AUD | 680,000 AUD | 510,000 AUD |
| 2015 | 9.84 M AUD | 608,990 AUD | 455,170 AUD |
| 2016 | 10.14 M AUD | 439,260 AUD | 302,470 AUD |
| 2017 | 5.88 M AUD | -20,760 AUD | 225,100 AUD |
| 2018 | 5.92 M AUD | 318,370 AUD | -1.24 M AUD |
| 2019 | 7.97 M AUD | 42,590 AUD | -1.72 M AUD |
| 2020 | 9.01 M AUD | 806,520 AUD | 1.48 M AUD |
| 2021 | 10.02 M AUD | 1.21 M AUD | 652,570 AUD |
| 2022 | 11.76 M AUD | 1.88 M AUD | 1.36 M AUD |
| 2023 | 11.94 M AUD | 1.52 M AUD | 1.41 M AUD |
| 2024 | 12.61 M AUD | 2.05 M AUD | 1.84 M AUD |
Cryosite stock margins AU000000CTE1 · 621943
The Cryosite margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cryosite. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cryosite.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Cryosite's sales revenue. A higher gross margin percentage indicates that the Cryosite retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Cryosite's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Cryosite's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cryosite's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cryosite. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cryosite's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Cryosite Margin History
| Cryosite Gross margin | Cryosite Profit margin | Cryosite EBIT margin | Cryosite Profit margin |
|---|---|---|---|
| 2024 | 63.38 % | 16.29 % | 14.59 % |
| 2023 | 60.11 % | 12.77 % | 11.81 % |
| 2022 | 58.16 % | 16 % | 11.6 % |
| 2021 | 58.8 % | 12.08 % | 6.51 % |
| 2020 | 44.85 % | 8.95 % | 16.42 % |
| 2019 | 42.26 % | 0.53 % | -21.6 % |
| 2018 | 57.2 % | 5.38 % | -20.94 % |
| 2017 | 51.25 % | -0.35 % | 3.83 % |
| 2016 | 40.6 % | 4.33 % | 2.98 % |
| 2015 | 51.17 % | 6.19 % | 4.62 % |
| 2014 | 51.59 % | 7.22 % | 5.41 % |
| 2013 | 53.65 % | 13.58 % | 14.27 % |
| 2012 | 51.25 % | 12.84 % | 12.72 % |
| 2011 | 48.65 % | 4.8 % | 4.95 % |
| 2010 | 46.58 % | 0.49 % | 0 % |
| 2009 | 49.84 % | -3.16 % | 0.16 % |
| 2008 | 50.97 % | 6.88 % | 6.73 % |
| 2007 | 52.45 % | 7.76 % | 18.78 % |
| 2006 | 50.35 % | 2.59 % | 2.35 % |
| 2005 | 43.79 % | -19.93 % | -20.26 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 43.79 % | -19.93 % | -20.26 % |
| 2006 | 50.35 % | 2.59 % | 2.35 % |
| 2007 | 52.45 % | 7.76 % | 18.78 % |
| 2008 | 50.97 % | 6.88 % | 6.73 % |
| 2009 | 49.84 % | -3.16 % | 0.16 % |
| 2010 | 46.58 % | 0.49 % | 0 % |
| 2011 | 48.65 % | 4.8 % | 4.95 % |
| 2012 | 51.25 % | 12.84 % | 12.72 % |
| 2013 | 53.65 % | 13.58 % | 14.27 % |
| 2014 | 51.59 % | 7.22 % | 5.41 % |
| 2015 | 51.17 % | 6.19 % | 4.62 % |
| 2016 | 40.6 % | 4.33 % | 2.98 % |
| 2017 | 51.25 % | -0.35 % | 3.83 % |
| 2018 | 57.2 % | 5.38 % | -20.94 % |
| 2019 | 42.26 % | 0.53 % | -21.6 % |
| 2020 | 44.85 % | 8.95 % | 16.42 % |
| 2021 | 58.8 % | 12.08 % | 6.51 % |
| 2022 | 58.16 % | 16 % | 11.6 % |
| 2023 | 60.11 % | 12.77 % | 11.81 % |
| 2024 | 63.38 % | 16.29 % | 14.59 % |
Cryosite Aktienanalyse
What does Cryosite do?
Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Cryosite's EBIT
Cryosite's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Cryosite's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Cryosite's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Cryosite’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Cryosite stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Cryosite.
How has the EBIT of Cryosite developed in recent years?
The EBIT of Cryosite has increased by 34.777% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Cryosite?
The EBIT of Cryosite is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Cryosite pay?
Over the past 12 months, Cryosite paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 8.24 %. For the coming 12 months, Cryosite is expected to pay a dividend of 0.07 AUD.
What is the dividend yield of Cryosite?
The current dividend yield of Cryosite is 8.24 %.
When does Cryosite pay dividends?
Cryosite pays a quarterly dividend. This is distributed in the months of October, October, March, October.
How secure is the dividend of Cryosite?
Cryosite paid dividends every year for the past 3 years.
What is the dividend of Cryosite?
For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 8.24 %.
In which sector is Cryosite located?
Cryosite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cryosite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cryosite from 10/10/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Cryosite pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cryosite in the year 2023?
In the year 2023, Cryosite distributed 0.015 AUD as dividends.
In which currency does Cryosite pay out the dividend?
The dividends of Cryosite are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cryosite
Our stock analysis for Cryosite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryosite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
